Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-LODD: Elobixibat for recovery of defecation desire in chronic constipation
jRCTs031210477Completed
- Sponsor
- Mochida Pharmaceutical Co., Ltd.
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of elobixibat in chronic constipation, sponsored by Mochida Pharmaceutical Co., Ltd. Primary endpoint: Primary: Rate of improvement in defecation desire. Started Mar 2022; status: completed.
02
Drugs
elobixibat
03
Conditions
chronic constipation
Beyond the preview
Go deeper on jRCTs031210477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031210477.